← Browse by Condition
Medical Condition

suicide

Total Trials
12
Recruiting Now
12
Trial Phases
Phase 2

ClinicalMetric tracks all active clinical trials for suicide sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — suicide Clinical Trials

How many clinical trials are currently recruiting for suicide?
ClinicalMetric currently tracks 12 actively recruiting clinical trials for suicide, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 12. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for suicide?
suicide research spans Phase 2 (2 trials). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a suicide clinical trial?
Eligibility criteria for suicide trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 2
2
Top Sponsors
University of California, Los Angeles 1 trial
University Health Network, Toronto 1 trial
University Hospital, Lille 1 trial
Oregon Health and Science University 1 trial
Massachusetts General Hospital 1 trial

Recruiting Clinical Trials

NCT05304065 Phase 2
Recruiting
Safe Treatment for Emergency Presentation for Suicidal Ideation and Behavior in Youth
Enrollment
1,600 pts
Location
United States
Sponsor
University of California, Los ...
View Trial →
NCT06480500 Phase 2
Recruiting
i-CBT and IV Ketamine for Suicidality in Treatment-Resistant Depression: A Randomized, Midazolam-Controlled Clinical Trial
Enrollment
110 pts
Location
Canada
Sponsor
University Health Network, Tor...
View Trial →
NCT04642157
Recruiting
Online Referral and Intervention to Prevent Adolescent and Young Adult Suicide
Enrollment
396 pts
Location
France
Sponsor
University Hospital, Lille
View Trial →
NCT02010866
Recruiting
Reaching Out to Distressed Medical Residents, Fellows and Faculty
Enrollment
4,000 pts
Location
United States
Sponsor
Oregon Health and Science Univ...
View Trial →
NCT05793541
Recruiting
Just-in-time Interventions for Reducing Short-term Suicide Risk
Enrollment
185 pts
Location
United States
Sponsor
Massachusetts General Hospital
View Trial →
NCT06770101
Recruiting
Suicide Assessment and Feasible Evidence-based Treatments for Youth Living With HIV in Lilongwe
Enrollment
60 pts
Location
Malawi
Sponsor
University of Pennsylvania
View Trial →
NCT05707975
Recruiting
Eco-anxiety and Suicide
Enrollment
261 pts
Location
France
Sponsor
Hospices Civils de Lyon
View Trial →
NCT07362056
Recruiting
Implementing Suicide Prevention Into Primary Care in Nepal
Enrollment
147 pts
Location
Nepal
Sponsor
Yale University
View Trial →
NCT05903469
Recruiting
Implicit and Explicit Assessment of Suicide Risk
Enrollment
108 pts
Location
France
Sponsor
Centre Hospitalier Universitai...
View Trial →
NCT06963463
Recruiting
Transdiagnostic Sleep and Circadian Intervention + Bright Light in Adolescents With Elevated Depression (TranS-C+BL)
Enrollment
90 pts
Location
United States
Sponsor
University of Pittsburgh
View Trial →
NCT05180344
Recruiting
Feasibility, Acceptability, and Preliminary Efficacy of a Novel Personalized Mobile Intervention for Suicide - Open Trial (2)
Enrollment
10 pts
Location
United States
Sponsor
Butler Hospital
View Trial →
NCT06660199
Recruiting
Text-based Support for Parents of Adolescents Following an Emergency Department Visits
Enrollment
420 pts
Location
United States
Sponsor
University of Michigan
View Trial →

Related Conditions

suicidal (2) depression (2) self harm (1) major depressive disorder (1) treatment resistant depression (1) hiv (1) suicide attempt (1) anxiety (1) primary care (1) implicit association test (1) prevention suicide (1) suicide risk factor (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology